• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAptorum
    Picture of Aptorum logo

    NIKI — Aptorum News Story

    $1.830.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    • Market Cap
      $6.60m
    • Enterprise Value
      -$2.72m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • NIKI Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    NIKI Dividends
    All News

    NASDAQ RESUMED

    Picture of Aptorum logoAptorum
    18/12/2018 17:17
    NASDAQ RESUMED  APM.O
    

    Recent news on Aptorum

    See all news
    • Brief: Niki Biosolutions Signs Agreement To Supply Apoe Genotyping To Charter Research

      23/10/2026 13:24
    • NASDAQ RESUMED AT 10:24 AM

      04/09/2026 15:24
    • NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:19 AM

      04/09/2026 15:19
    • Niki BioSolutions weighs financing options as going-concern warning clouds post-merger outlook

      21/08/2026 22:15
    • NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM

      19/07/2026 08:28

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.